Resources for schools and students We are passionate about inspiring the cancer researchers of the future. We engage with local secondary schools in Sutton, Kensington and Chelsea and the surrounding ...

In 1995, our researchers discovered the cancer gene BRCA2, which, when mutated, can make carriers more likely to develop cancer.

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

Our leadership teamProfessor Kristian Helin Chief Executive and President The Chief Executive is responsible to the Board of Trustees for the overall direction of the ICR’s management, research and ...

The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...

Improving access to clinical trials Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for ...

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy.

The Institute of Cancer Research, London, is one of the world's most influential cancer research organisations, with an outstanding record of achievement.

The Institute of Cancer Research, London, is one of the world's most influential cancer research organisations, with an outstanding record of achievement.

An immunotherapy treatment helps patients live years longer without their cancer getting worse or coming back, a major phase III trial has found.

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...